United States Regenerative Medicine Market Report 2018

March 2018 | 110 pages | ID: U335BB6C194EN
QYResearch

Abstracts

In this report, the United States Regenerative Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Regenerative Medicine in these regions, from 2013 to 2025 (forecast).

United States Regenerative Medicine market competition by top manufacturers/players, with Regenerative Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aastrom Biosciences Inc
• Advanced Cell Technology
• Athersys Inc
• Amgen Inc
• Bioheart Inc
• Cytori Therapeutics Inc
• Celgene Corporation
• Geron Corporation
• Genzyme Corporation
• Osiris Therapeutics Inc
• Japan Tissue Engineering Co
• Thermogenesis Corp
• Mesoblast, Inc
• Vertex Pharmaceuticals, Inc
• Organogenesis, Inc
• Nuvasive, Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Cell Therapy (Ct) Based Products
• Tissue Engineered (Te) Products
• Bone and Cartilage Grafting and Regenerative Products
• Electrical Stimulators
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Bone And Joints Replacement
• Dental
• Neurological
• Organ Regeneration
• Cardiovascular Disorders
• Wound Care
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Regenerative Medicine Market Report 2018

1 REGENERATIVE MEDICINE OVERVIEW

1.1 Product Overview and Scope of Regenerative Medicine
1.2 Classification of Regenerative Medicine by Product Category
  1.2.1 United States Regenerative Medicine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Regenerative Medicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Cell Therapy (Ct) Based Products
  1.2.4 Tissue Engineered (Te) Products
  1.2.5 Bone and Cartilage Grafting and Regenerative Products
  1.2.6 Electrical Stimulators
  1.2.7 Others
1.3 United States Regenerative Medicine Market by Application/End Users
  1.3.1 United States Regenerative Medicine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Bone And Joints Replacement
  1.3.3 Dental
  1.3.4 Neurological
  1.3.5 Organ Regeneration
  1.3.6 Cardiovascular Disorders
  1.3.7 Wound Care
  1.3.8 Others
1.4 United States Regenerative Medicine Market by Region
  1.4.1 United States Regenerative Medicine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Regenerative Medicine Status and Prospect (2013-2025)
  1.4.3 Southwest Regenerative Medicine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Regenerative Medicine Status and Prospect (2013-2025)
  1.4.5 New England Regenerative Medicine Status and Prospect (2013-2025)
  1.4.6 The South Regenerative Medicine Status and Prospect (2013-2025)
  1.4.7 The Midwest Regenerative Medicine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Regenerative Medicine (2013-2025)
  1.5.1 United States Regenerative Medicine Sales and Growth Rate (2013-2025)
  1.5.2 United States Regenerative Medicine Revenue and Growth Rate (2013-2025)

2 UNITED STATES REGENERATIVE MEDICINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Regenerative Medicine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Regenerative Medicine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Regenerative Medicine Average Price by Players/Suppliers (2013-2018)
2.4 United States Regenerative Medicine Market Competitive Situation and Trends
  2.4.1 United States Regenerative Medicine Market Concentration Rate
  2.4.2 United States Regenerative Medicine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Regenerative Medicine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES REGENERATIVE MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Regenerative Medicine Sales and Market Share by Region (2013-2018)
3.2 United States Regenerative Medicine Revenue and Market Share by Region (2013-2018)
3.3 United States Regenerative Medicine Price by Region (2013-2018)

4 UNITED STATES REGENERATIVE MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Regenerative Medicine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Regenerative Medicine Revenue and Market Share by Type (2013-2018)
4.3 United States Regenerative Medicine Price by Type (2013-2018)
4.4 United States Regenerative Medicine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES REGENERATIVE MEDICINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Regenerative Medicine Sales and Market Share by Application (2013-2018)
5.2 United States Regenerative Medicine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES REGENERATIVE MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aastrom Biosciences Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Regenerative Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aastrom Biosciences Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Advanced Cell Technology
  6.2.2 Regenerative Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Advanced Cell Technology Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Athersys Inc
  6.3.2 Regenerative Medicine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Athersys Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Amgen Inc
  6.4.2 Regenerative Medicine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Bioheart Inc
  6.5.2 Regenerative Medicine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bioheart Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Cytori Therapeutics Inc
  6.6.2 Regenerative Medicine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cytori Therapeutics Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Celgene Corporation
  6.7.2 Regenerative Medicine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Celgene Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Geron Corporation
  6.8.2 Regenerative Medicine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Geron Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Genzyme Corporation
  6.9.2 Regenerative Medicine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genzyme Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Osiris Therapeutics Inc
  6.10.2 Regenerative Medicine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Osiris Therapeutics Inc Regenerative Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Japan Tissue Engineering Co
6.12 Thermogenesis Corp
6.13 Mesoblast, Inc
6.14 Vertex Pharmaceuticals, Inc
6.15 Organogenesis, Inc
6.16 Nuvasive, Inc

7 REGENERATIVE MEDICINE MANUFACTURING COST ANALYSIS

7.1 Regenerative Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Regenerative Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Regenerative Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Regenerative Medicine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES REGENERATIVE MEDICINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Regenerative Medicine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Regenerative Medicine Sales Volume Forecast by Type (2018-2025)
11.3 United States Regenerative Medicine Sales Volume Forecast by Application (2018-2025)
11.4 United States Regenerative Medicine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Regenerative Medicine
Figure United States Regenerative Medicine Market Size (K Units) by Type (2013-2025)
Figure United States Regenerative Medicine Sales Volume Market Share by Type (Product Category) in 2017
Figure Cell Therapy (Ct) Based Products Product Picture
Figure Tissue Engineered (Te) Products Product Picture
Figure Bone and Cartilage Grafting and Regenerative Products Product Picture
Figure Electrical Stimulators Product Picture
Figure Others Product Picture
Figure United States Regenerative Medicine Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Regenerative Medicine by Application in 2017
Figure Bone And Joints Replacement Examples
Table Key Downstream Customer in Bone And Joints Replacement
Figure Dental Examples
Table Key Downstream Customer in Dental
Figure Neurological Examples
Table Key Downstream Customer in Neurological
Figure Organ Regeneration Examples
Table Key Downstream Customer in Organ Regeneration
Figure Cardiovascular Disorders Examples
Table Key Downstream Customer in Cardiovascular Disorders
Figure Wound Care Examples
Table Key Downstream Customer in Wound Care
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Regenerative Medicine Market Size (Million USD) by Region (2013-2025)
Figure The West Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Regenerative Medicine Sales (K Units) and Growth Rate (2013-2025)
Figure United States Regenerative Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Regenerative Medicine Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Regenerative Medicine Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Regenerative Medicine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Regenerative Medicine Sales Share by Players/Suppliers
Figure 2017 United States Regenerative Medicine Sales Share by Players/Suppliers
Figure United States Regenerative Medicine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Regenerative Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Regenerative Medicine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Regenerative Medicine Revenue Share by Players/Suppliers
Figure 2017 United States Regenerative Medicine Revenue Share by Players/Suppliers
Table United States Market Regenerative Medicine Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Regenerative Medicine Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Regenerative Medicine Market Share of Top 3 Players/Suppliers
Figure United States Regenerative Medicine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Regenerative Medicine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Regenerative Medicine Product Category
Table United States Regenerative Medicine Sales (K Units) by Region (2013-2018)
Table United States Regenerative Medicine Sales Share by Region (2013-2018)
Figure United States Regenerative Medicine Sales Share by Region (2013-2018)
Figure United States Regenerative Medicine Sales Market Share by Region in 2017
Table United States Regenerative Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Regenerative Medicine Revenue Share by Region (2013-2018)
Figure United States Regenerative Medicine Revenue Market Share by Region (2013-2018)
Figure United States Regenerative Medicine Revenue Market Share by Region in 2017
Table United States Regenerative Medicine Price (USD/Unit) by Region (2013-2018)
Table United States Regenerative Medicine Sales (K Units) by Type (2013-2018)
Table United States Regenerative Medicine Sales Share by Type (2013-2018)
Figure United States Regenerative Medicine Sales Share by Type (2013-2018)
Figure United States Regenerative Medicine Sales Market Share by Type in 2017
Table United States Regenerative Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Regenerative Medicine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Regenerative Medicine by Type (2013-2018)
Figure Revenue Market Share of Regenerative Medicine by Type in 2017
Table United States Regenerative Medicine Price (USD/Unit) by Types (2013-2018)
Figure United States Regenerative Medicine Sales Growth Rate by Type (2013-2018)
Table United States Regenerative Medicine Sales (K Units) by Application (2013-2018)
Table United States Regenerative Medicine Sales Market Share by Application (2013-2018)
Figure United States Regenerative Medicine Sales Market Share by Application (2013-2018)
Figure United States Regenerative Medicine Sales Market Share by Application in 2017
Table United States Regenerative Medicine Sales Growth Rate by Application (2013-2018)
Figure United States Regenerative Medicine Sales Growth Rate by Application (2013-2018)
Table Aastrom Biosciences Inc Basic Information List
Table Aastrom Biosciences Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aastrom Biosciences Inc Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Aastrom Biosciences Inc Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Aastrom Biosciences Inc Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Advanced Cell Technology Basic Information List
Table Advanced Cell Technology Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advanced Cell Technology Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Advanced Cell Technology Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Advanced Cell Technology Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Athersys Inc Basic Information List
Table Athersys Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Athersys Inc Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Athersys Inc Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Athersys Inc Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Amgen Inc Basic Information List
Table Amgen Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Inc Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Amgen Inc Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Amgen Inc Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Bioheart Inc Basic Information List
Table Bioheart Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bioheart Inc Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Bioheart Inc Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Bioheart Inc Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Cytori Therapeutics Inc Basic Information List
Table Cytori Therapeutics Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cytori Therapeutics Inc Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Cytori Therapeutics Inc Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Cytori Therapeutics Inc Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Corporation Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Celgene Corporation Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Celgene Corporation Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Geron Corporation Basic Information List
Table Geron Corporation Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Geron Corporation Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Geron Corporation Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Geron Corporation Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Genzyme Corporation Basic Information List
Table Genzyme Corporation Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genzyme Corporation Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Genzyme Corporation Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Genzyme Corporation Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Osiris Therapeutics Inc Basic Information List
Table Osiris Therapeutics Inc Regenerative Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Osiris Therapeutics Inc Regenerative Medicine Sales Growth Rate (2013-2018)
Figure Osiris Therapeutics Inc Regenerative Medicine Sales Market Share in United States (2013-2018)
Figure Osiris Therapeutics Inc Regenerative Medicine Revenue Market Share in United States (2013-2018)
Table Japan Tissue Engineering Co Basic Information List
Table Thermogenesis Corp Basic Information List
Table Mesoblast, Inc Basic Information List
Table Vertex Pharmaceuticals, Inc Basic Information List
Table Organogenesis, Inc Basic Information List
Table Nuvasive, Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Regenerative Medicine
Figure Manufacturing Process Analysis of Regenerative Medicine
Figure Regenerative Medicine Industrial Chain Analysis
Table Raw Materials Sources of Regenerative Medicine Major Players/Suppliers in 2017
Table Major Buyers of Regenerative Medicine
Table Distributors/Traders List
Figure United States Regenerative Medicine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Regenerative Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Regenerative Medicine Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Regenerative Medicine Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Regenerative Medicine Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Regenerative Medicine Sales Volume (K Units) Forecast by Type in 2025
Table United States Regenerative Medicine Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Regenerative Medicine Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Regenerative Medicine Sales Volume (K Units) Forecast by Application in 2025
Table United States Regenerative Medicine Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Regenerative Medicine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Regenerative Medicine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Regenerative Medicine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources